Expert Opinion on Emerging Drugs

Papers
(The H4-Index of Expert Opinion on Emerging Drugs is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity59
Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials35
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials22
Emerging synthetic drugs for the treatment of liver cirrhosis17
Epilepsy: expert opinion on emerging drugs in phase 2/3 clinical trials15
Emerging PD-1/PD-L1 antagonists for the treatment of malignant melanoma14
Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa14
Emerging therapeutics in Huntington’s disease14
Emerging drugs for the treatment of adult MOG-IgG-associated diseases12
Emerging therapies for dry eye disease12
Designing phase II clinical trials in Friedreich ataxia11
0.2381579875946